176 related articles for article (PubMed ID: 24909613)
1. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.
Kamikawa Y; Kanmura Y; Hamada T; Yamada N; Macha MA; Batra SK; Higashi M; Yonezawa S; Sugihara K
Int J Clin Oncol; 2015 Apr; 20(2):298-307. PubMed ID: 24909613
[TBL] [Abstract][Full Text] [Related]
2. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
3. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
[TBL] [Abstract][Full Text] [Related]
4. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of muc4 expression in gallbladder carcinoma.
Lee HK; Cho MS; Kim TH
World J Surg Oncol; 2012 Oct; 10():224. PubMed ID: 23101681
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.
Yanase M; Kato K; Yoshizawa K; Noguchi N; Kitahara H; Nakamura H
J Oral Pathol Med; 2014 Aug; 43(7):514-20. PubMed ID: 24762199
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer.
Kim JW; Park Y; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2016 Oct; 21(5):883-889. PubMed ID: 27000845
[TBL] [Abstract][Full Text] [Related]
9. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
10. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Rathee R; Devi A; Narwal A; Kamboj M; Singh S
Head Neck Pathol; 2021 Sep; 15(3):831-842. PubMed ID: 33544383
[TBL] [Abstract][Full Text] [Related]
12. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
13. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
Weed DT; Gomez-Fernandez C; Yasin M; Hamilton-Nelson K; Rodriguez M; Zhang J; Carraway KL
Laryngoscope; 2004 Aug; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.
Kaur S; Momi N; Chakraborty S; Wagner DG; Horn AJ; Lele SM; Theodorescu D; Batra SK
PLoS One; 2014; 9(3):e92742. PubMed ID: 24671186
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
19. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
